Search

Your search keyword '"Hendin, Barry A"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Hendin, Barry A" Remove constraint Author: "Hendin, Barry A"
39 results on '"Hendin, Barry A"'

Search Results

2. Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

5. Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?

7. One-year Analysis of Efficacy and Safety Data from Black/African American and Hispanic/Latino People with Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (PL5.005)

9. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

13. Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon-Beta-1a (Avonex)

16. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

17. Supplemental material for Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results

21. (DMT33) One-Year Analysis of Ocrelizumab Treatment in Black/African American and Hispanic/Latino Patients With Relapsing Multiple Sclerosis From the CHIMES Trial.

22. Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

23. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

24. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

26. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes

28. Predicting missing biomarker data in a longitudinal study of Alzheimer disease

31. Sex-dependent association of common variants of microcephaly genes with brain structure

32. Hexanucleotide repeat expansions in C9ORF72in the spectrum of motor neuron diseases

36. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

37. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly

38. Cerebellar Degeneration With Hodgkin Disease: An Immunological Study

39. Coccidioidal Meningitis Narcotic—Amphotericin B Intracisternal Therapy

Catalog

Books, media, physical & digital resources